A Giant Stumbles

Gopal,Kevin;

Article

Pharmaceutical Executive

July 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-07-01-2001

Volume0

Issue 0

A Giant Stumbles

Author(s):

Kevin Gopal

Basel, Switzerland—Roche, which recently slashed its work force by 3,000, maintains that it will remain independent even after the sale of 20 percent of the company to Novartis. Franz Humer, the troubled company’s chairman, says the founding family supports Roche’s strategy.

Articles in this issue

Pharmacies: OTC Price Wars

One Disease at a Time

Overview of the Industry: A World of Opportunities

The Power Shift

A Giant Stumbles

Overruled: No More Dual Pricing

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

A Giant Stumbles

Newsletter